Neurocognitive Risk May Begin Before Treatment for Young Leukemia Patients

Newswise imageChemotherapy agents have been associated with neurocognitive side effects in young leukemia survivors. Now St. Jude Children’s Research Hospital scientists have evidence the disease and genetics might also play a role.

Source link

Related posts

How to Safely Love the Sun


Perceptions of Parental Tobacco Dependence Treatment Among a Childrens Hospital Staff


Opportunities to Improve Inpatient Care for Children With Behavioral Comorbidities


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World